CERIBELL INC
CBLLNASDAQTrading Snapshot
- Day Range
- โ
- 52-Week Range
- $14.87 โ $28.89
- Volume (shares)
- โ
- Avg Volume (shares)
- โ
- Shares Outstanding
- 38.8M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- $89M
- Last Q Revenue
- $29M
- P/E Ratio
- -14.1
- P/S Ratio
- 9.8x
- EPS (TTM)
- $-1.92
- Dividend Yield
- 0.00%
CERIBELL INC
CBLLFinancial history unavailable.
About CERIBELL INC
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.